Group Preconception Care for Fertility Patients

Sponsor
University of Pennsylvania (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05924464
Collaborator
Pomelo Care, Inc. (Other), Independence Blue Cross (Other)
140
2
23

Study Details

Study Description

Brief Summary

Group Preconception Care for Fertility Patients aims to translate the well-established group prenatal care model to preconception care to improve pregnancy and neonatal outcomes. In partnership with Pomelo Care (a virtual maternity care program), the investigators are conducting this study using couples at Penn Fertility Care.

Condition or Disease Intervention/Treatment Phase
  • Other: Group Preconception Care
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
140 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Group Preconception Care for Fertility Patients
Anticipated Study Start Date :
Jun 30, 2023
Anticipated Primary Completion Date :
May 30, 2025
Anticipated Study Completion Date :
May 30, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention arm

Group preconception care

Other: Group Preconception Care
Groups of 6-10 patients to initiate biweekly virtual group care sessions on a rolling basis, with completion of enrollment and the virtual curriculum within a year.

No Intervention: Control arm

Usual care (completion of questionnaires only)

Outcome Measures

Primary Outcome Measures

  1. Blood pressure measurement recorded by clinician in Penn EMR [From enrollment to 16 weeks]

    Was a blood pressure measurement recorded by a clinician in Penn EMR, yes/no

  2. Weight measurement recorded by clinician in Penn EMR [From enrollment to 16 weeks]

    Was a weight measurement recorded by a clinician in Penn EMR, yes/no

  3. Hemoglobin A1c testing results recorded in Penn EMR [From enrollment to 16 weeks]

    Was a hemoglobin A1c test performed if medically indicated (history of diabetes, BMI>30) or felt necessary by health care provider, yes/no

  4. Change in Anxiety screening score [Enrollment, 4 months, 12 months]

    Generalized Anxiety Disorder 7 (GAD-7) Questionnaire will be administered to both groups at enrollment, 4 months, and 12 months. The total score for the seven items ranges from 0 to 21, with 21 indicating a worse outcome

  5. Change in Depression screening score [Enrollment, 4 months, 12 months]

    Patient Health Questionnaire 9 (PHQ-9) will be administered to both groups at enrollment, 4 months, and 12 months. The total score for the nine items ranges from 0 to 27 where a high score indicates a worse outcome

  6. Change in Fertility-related quality of life questionnaire score [Enrollment, 4 months, 12 months]

    Fertility Related Quality of Life (FertiQOL) Questionnaire will be administered to both groups at enrollment, 4 months, and 12 months. The 36 FertiQoL items are rated according to 5 types of response scales. The total score is 100, with higher scores indicating worse fertility-related quality of life.

  7. Incidence of ovulation stimulations [From enrollment to 12 months]

    Count of ovarian stimulation treatments

  8. Incidence of intrauterine inseminations [From enrollment to 12 months]

    Count of intrauterine insemination treatments

  9. Incidence of in vitro fertilizations [From enrollment to 12 months]

    Count of in vitro fertilization treatments

  10. Pregnancy rate [From enrollment to 12 months]

    This includes the number of patients who become pregnant during the study period in both groups.

  11. Time to pregnancy in days [From enrollment to 12 months]

    This includes the time until patients become pregnant during the study period in both groups.

  12. Patient experience [Enrollment to 16 weeks]

    In the intervention arm only, brief questionnaires will be distributed after each virtual session to ask participants to rate their satisfaction with the session. Patients will also complete a cumulative evaluation at the conclusion of the sessions. These surveys will use a Likert scale with a higher score indicating a better experience.

  13. Miscarriage rate [From enrollment up to 18 months]

    Total number of miscarriages per participants who become pregnant in either group

  14. Number of pregnant participants with occurrence of a hypertensive disorder of pregnancy [Conception to delivery, approximately 9 months]

    This will be scored yes if any of the following are noted in the medical record: gestational hypertension (blood pressure >140/90 on 2 or more occasions at least 4 hours apart), severe preeclampsia (blood pressure >160/110 on 2 or more occasions at least 4 hours apart, or mildly elevated blood pressures with persistent headache, scotomata, platelet count <100,000/uL, liver function tests twice the upper limit of normal, or creatinine >1.1 mg/dL), HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count), or eclampsia (elevated blood pressure with seizures).

  15. Number of pregnant participants with a diagnosis of gestational diabetes [Conception to delivery, approximately 9 months]

    This will be scored yes if gestational diabletes is diagnosed. Gestational diabetes is diagnosed based on an abnormal 3-hour glucose tolerance test (1-hour test blood glucose >135mg/dL will be followed by a 3-hour test). Two or more abnormal values on the 3-hour test is diagnostic of gestational diabetes. Cutoffs are 95 fasting, 180 at 1 hour, 155 at 2 hours, and 140 at 3 hours.

  16. Number of pregnant participants with occurrences with an antepartum hospitalizations [Conception to delivery, approximately 9 months]

    This includes hospital admissions during the pregnancy for any pregnancy or non-pregnancy related complications.

  17. Number of pregnant participants with preterm birth [At time of delivery]

    Preterm delivery is defined as delivery at less than 37 weeks gestational age.

  18. Number of pregnant participants with a cesarean delivery [At time of delivery]

    In participants who become pregnant, the incidence of cesarean delivery

  19. Number of pregnant participants with a NICU admission [From date of delivery to date of discharge from hospital postpartum, up to 6 weeks from delivery]

    Infant admission to neonatal intensive care unit.

  20. Number of PEC (Perinatal Evaluation Center)/emergency room visits in pregnant participants [From date of conception to delivery date, approximately 9 months]

    Total number of any presentation to the Perinatal Evaluation Center or emergency room during pregnancy

  21. Among those patients that become pregnant, delivery length of stay [From date of delivery to date of discharge from hospital postpartum, up to six weeks from delivery]

    Length of stay from birth to discharge, measured in hours

  22. Among those patients that become pregnant, score on the Edinburgh Postnatal Depression Scale [Between 2 to 6 weeks after delivery]

    Edinburgh Postnatal Depression Scale will either be abstracted from the medical record, or if not administered clinically, will be administered by the study team. The total score for the ten items ranges from 0 to 30 with a higher score indicating a worse outcome.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Female new patient seen at Penn Fertility Care for infertility or procreative management

  2. Currently planning to conceive

  3. Intending to carry pregnancy (i.e. will not need a gestational carrier), since our project aims to implement lifestyle changes prior to conception

  4. Willing to be randomized to group preconception care versus usual care

Exclusion Criteria:
  1. Prior infertility treatment at other practice in this initial project, we aim to focus on patients with a new diagnosis of infertility to allow time for completion of the virtual program during the diagnostic phase and early treatment phase

  2. Known need for gestational carrier, as above

  3. Planning preimplantation genetic testing for monogenic disorders or egg/embryo banking

  4. Non-English speaking

  5. Unable to complete electronic questionnaires due to lack of access to technology

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University of Pennsylvania
  • Pomelo Care, Inc.
  • Independence Blue Cross

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Anuja Dokras, Director of the Penn PCOS Center, University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT05924464
Other Study ID Numbers:
  • 852900
First Posted:
Jun 29, 2023
Last Update Posted:
Jun 29, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 29, 2023